Back to search
Pediatric Bipolar Spectrum Disorders
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Pediatric Bipolar Spectrum Disorders trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Pediatric Bipolar Spectrum Disorders trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This is a multicenter, global, 26-week, open-label study to assess the safety and tolerability of lumateperone in pediatric patients with schizophrenia, bipolar…
This is a study of the efficacy and safety of BXCL501 in children and adolescents with acute agitation and either bipolar disorder or schizophrenia.
To compare changes in body mass index (BMI) Z-score following treatment with OLZ/SAM vs olanzapine
To provide continued access to OLZ/SAM for pediatric participants with schizophrenia or bipolar I disorder who have completed participation in the ALKS 3831-A31…
To evaluate the long-term safety and tolerability of OLZ/SAM in pediatric subjects with schizophrenia or Bipolar I disorder